Joshua Bell

AREAS OF EXPERTISE

M&A; Capital Raisings; Shareholder Arrangements; Corporate Advisory; Foreign Investment Regulations

QUALIFICATIONS

• Certificate in CTA1 Foundations of Tax – Tax Institute
• Graduate Diploma in Legal Practice – Australia National University
• Bachelor of Laws (Hons) – The University of Adelaide
• Bachelor of International Studies (History and Politics) – The University of Adelaide
• Admitted to practice in New South Wales and South Australia

SELECTED REPRESENTATIONS

• Advising MA Growth Ventures on a $20m growth capital investment into the DoctorSquare group and the associated acquisition of 24-7 Healthcare Group from Crescent Capital Partners.
• Acting on the sale of Lexicon Group to Endava LLC, a NYSE listed UK multinational consultancy business.
• Advising Energy Impact Partners, a US-based impact investor, , on a US$17m equity investment into Infravision, an Australian drone stringing business as part of a US$23m round which included Equinor Ventures and Edison International.
• Advising Sia Partners, a French-based global management consulting group, on the acquisition of Churchill Consulting.
• Advising Xplore Wealth Limited (ASX: XPL) on its $60 million acquisition by HUB24 Limited (ASX: HUB) for a mixture of cash and scrip by way of a concurrent share scheme of arrangement and option scheme of arrangement.
• Advising on the sale of Partizan Worldwide, a leading patient support healthcare solutions provider in the Australian pharmaceutical market, to DKSH Healthcare, a Swiss-based global provider of market expansion services for healthcare companies.
• Advising Refratechnik Group on the acquisition of leading magnesia producer QMAG Limited from Sibelco.
• Acting for the founder of Kounta, a POS solutions provider, on the $84 million acquisition of Kounta by Lightspeed POS Inc, a Canadian listed entity.
• Acting for the shareholders of a national trucking and logistics group in the sale of their shares to Silk Logistics Group.
• Acting for a global FMCG Group on a complex multibillion-dollar restructure of its Australian assets and businesses.
• Advising MedAdvisor Limited (ASX: MDR) on the establishment of a Singapore-based joint venture with Asian healthcare company, Zuellig Pharmaceuticals.
• Acting for Mazars, a global accounting firm, on its mergers with Hanrick Curran and Cummings Flavel McCormack.
• Advising MA Growth Ventures on multiple portfolio investments (equity and convertible notes) into fast growing technology businesses, including Sonder, Demyst, Quantum Brilliance, and Liquid Instruments.
• Advising Tank Stream Ventures and the BridgeLane Group on various portfolio investments, including ezyCollect, Biteable, Equitise, Go1, Agerris, Sprout Stack, Flare HR, and Wirely.
• Advising Yellow Canary, a workplace compliance platform, on an equity capital raise from Parc Capital.
• Advising Partners for Growth, Longreach and One Ventures on multiple warrant arrangements in connection with secured venture debt transactions with Australian and multi-national growth companies.